- IN₹4.53bn
- IN₹5.77bn
- IN₹3.34bn
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls
Brief: SMS Lifesciences India Ltd June-Quarter Consol Net Profit Falls
Brief: SMS Lifesciences India Executes Share Purchase, Share-Subscription Agreements With Chemwerth Inc USA
Brief: SMS Lifesciences India Reports Higher March-Quarter Consol Net Profit
Brief: SMS Lifesciences India Sept-Qtr Consol Net Profit Slips
Brief: India's Sms Lifesciences India June Quarter Consol Net PAT Falls
Brief: SMS Lifesciences India March-Qtr Consol Net Profit Drops
Brief: Reduced Usage Of Ranitidine, Lockdown Could Impact Revenues Of SMS Lifesciences India
Brief: SMS Lifesciences India Reports Dec Qtr Net Loss Of 2.9 Mln Rupees
Brief: SMS Lifesciences India Sept-Quarter Profit Falls
Brief: SMS Lifesciences: Preliminary Analysis Finds NMDA Impurity In Trace Levels In Ranitidine
Brief: SMS Lifesciences India Sept-Qtr Net Profit Rises
Brief: SMS Lifesciences India Acquires 1 Mln Shares In Mahi Drugs
Brief: SMS Lifesciences India June Quarter Net Profit Jumps
Brief: SMS Lifesciences India Approves Acquisition Of Mahi Drugs
Brief: SMS Lifesciences India Deferred Issue Of NCDs